All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-32929472

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32929472	E138K	IN	gag-pol	HIV Infections	D G C L	View
2	32929472	G163R	IN	gag-pol	HIV Infections	D G C L	View
3	32929472	K103N	RT	gag-pol	HIV Infections	D G C L	View
4	32929472	K103S	RT	gag-pol	HIV Infections	D G C L	View
5	32929472	L74I	IN	gag-pol	HIV Infections	D G C L	View
6	32929472	L74M	IN	gag-pol	HIV Infections	D G C L	View
7	32929472	L90M	PR	gag-pol	HIV Infections	D G C L	View
8	32929472	M41L	RT	gag-pol	HIV Infections	D G C L	View
9	32929472	M46L	PR	gag-pol	HIV Infections	D G C L	View
10	32929472	Q148H	IN	gag-pol	HIV Infections	D G C L	View
11	32929472	Q95K	IN	gag-pol	HIV Infections	D G C L	View
12	32929472	R263K	IN	gag-pol	HIV Infections	D G C L	View
13	32929472	S230R	IN	gag-pol	HIV Infections	D G C L	View
14	32929472	T97A	IN	gag-pol	HIV Infections	D G C L	View
15	32929472	Y188C	RT	gag-pol	HIV Infections	D G C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.